135 related articles for article (PubMed ID: 31613863)
1. Local Adjuvant Substances Following Curettage of Bone Tumors.
Bickels J; Campanacci DA
J Bone Joint Surg Am; 2020 Jan; 102(2):164-174. PubMed ID: 31613863
[No Abstract] [Full Text] [Related]
2. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.
; Becker WT; Dohle J; Bernd L; Braun A; Cserhati M; Enderle A; Hovy L; Matejovsky Z; Szendroi M; Trieb K; Tunn PU
J Bone Joint Surg Am; 2008 May; 90(5):1060-7. PubMed ID: 18451399
[TBL] [Abstract][Full Text] [Related]
3. Local adjuvants in surgical management of bone metastases.
Piccioli A; Ventura A; Maccauro G; Spinelli MS; Del Bravo V; Rosa MA
Int J Immunopathol Pharmacol; 2011; 24(1 Suppl 2):129-32. PubMed ID: 21669151
[TBL] [Abstract][Full Text] [Related]
4. Subchondral giant-cell tumor of the proximal tibia: arthroscopic treatment for accelerated articular cartilage and meniscal degeneration in two patients.
Tejwani SG; Hame SL; Eckardt JJ
Arthroscopy; 2004 Jul; 20(6):644-9. PubMed ID: 15241319
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study.
Savadkoohi DG; Sadeghipour P; Attarian H; Sardari S; Eslamifar A; Shokrgozar MA
J Bone Joint Surg Br; 2008 Jul; 90(7):973-9. PubMed ID: 18591612
[TBL] [Abstract][Full Text] [Related]
6. Mid-term results of intralesional extended curettage, cauterization, and polymethylmethacrylate cementation in the treatment of giant cell tumor of bone: A retrospective case series.
Şirin E; Akgülle AH; Topkar OM; Sofulu Ö; Baykan SE; Erol B
Acta Orthop Traumatol Turc; 2020 Sep; 54(5):524-529. PubMed ID: 33155564
[TBL] [Abstract][Full Text] [Related]
7. Soft tissue extension increases the risk of local recurrence after curettage with adjuvants for giant-cell tumor of the long bones.
van der Heijden L; van de Sande MA; Dijkstra PD
Acta Orthop; 2012 Aug; 83(4):401-5. PubMed ID: 22880716
[TBL] [Abstract][Full Text] [Related]
8. The role and biology of cryosurgery in the treatment of bone tumors. A review.
Bickels J; Meller I; Shmookler BM; Malawer MM
Acta Orthop Scand; 1999 Jun; 70(3):308-15. PubMed ID: 10429612
[TBL] [Abstract][Full Text] [Related]
9. Treatment of stages 2 and 3 giant-cell tumor.
Labs K; Perka C; Schmidt RG
Arch Orthop Trauma Surg; 2001; 121(1-2):83-6. PubMed ID: 11195127
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for recurrent giant cell tumors of bone.
Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy.
Trieb K; Bitzan P; Lang S; Dominkus M; Kotz R
Eur J Surg Oncol; 2001 Mar; 27(2):200-2. PubMed ID: 11289759
[TBL] [Abstract][Full Text] [Related]
12. Giant cell tumor of bone: risk factors for recurrence.
Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
[TBL] [Abstract][Full Text] [Related]
13. Comparison of phenol and argon beam coagulation as adjuvant therapies in the treatment of stage 2 and 3 benign-aggressive bone tumors.
Benevenia J; Patterson FR; Beebe KS; Abdelshahed MM; Uglialoro AD
Orthopedics; 2012 Mar; 35(3):e371-8. PubMed ID: 22385449
[TBL] [Abstract][Full Text] [Related]
14. Aggressive treatment of giant cell tumour with multiple local adjuvants.
Ofluoglu O
Acta Orthop Belg; 2008 Dec; 74(6):831-6. PubMed ID: 19205332
[TBL] [Abstract][Full Text] [Related]
15. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups).
Gouin F; Dumaine V;
Orthop Traumatol Surg Res; 2013 Oct; 99(6 Suppl):S313-8. PubMed ID: 23978709
[TBL] [Abstract][Full Text] [Related]
16. [Curettage plus cement reconstruction for treating giant cell tumor of limbs].
Zhang Q; Cai Y; Niu X; Hao L
Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):730-2. PubMed ID: 11829938
[TBL] [Abstract][Full Text] [Related]
17. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone.
Dürr HR; Maier M; Jansson V; Baur A; Refior HJ
Eur J Surg Oncol; 1999 Dec; 25(6):610-8. PubMed ID: 10556009
[TBL] [Abstract][Full Text] [Related]
18. Giant cell tumor of bone. Curettage and cement reconstruction.
Bini SA; Gill K; Johnston JO
Clin Orthop Relat Res; 1995 Dec; (321):245-50. PubMed ID: 7497676
[TBL] [Abstract][Full Text] [Related]
19. Complications associated with bone cementing for the treatment of giant cell tumors of bone.
Wada T; Kaya M; Nagoya S; Kawaguchi S; Isu K; Yamashita T; Yamawaki S; Ishii S
J Orthop Sci; 2002; 7(2):194-8. PubMed ID: 11956979
[TBL] [Abstract][Full Text] [Related]
20. Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis.
Zuo D; Zheng L; Sun W; Fu D; Hua Y; Cai Z
World J Surg Oncol; 2013 Jul; 11():156. PubMed ID: 23866921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
